Investor Relations

Press Releases

 
Press Releases
  Date Title View
Jan 6, 2015
SILVER SPRING, Md., Jan. 6, 2015 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) announced today that Martine Rothblatt, Ph.D., Chairman and Co-Chief Executive Officer, and Roger Jeffs, Ph.D., President and Co-Chief Executive Officer, of United Therapeutics will provide an overview and update on the company's business at the 33rd Ann...
Dec 31, 2014
SILVER SPRING, Md., Dec. 31, 2014 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) announced today the signing of an agreement with DEKA Research & Development Corp. for the development of a potential technology breakthrough in the subcutaneous delivery of Remodulin® (treprostinil) Injection to patients with pulmonary arterial hy...
Dec 24, 2014
SILVER SPRING, Md., Dec. 24, 2014 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) announced today that Medtronic, Inc. (NYSE: MDT) has submitted a pre-market approval application to the U.S. Food and Drug Administration (FDA) for the use of Medtronic's SynchroMed® II implantable drug infusion system (including a newly developed ...
Dec 17, 2014
SILVER SPRING, Md., Dec. 17, 2014 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) announced today two senior executive promotions as well as changes to Martine Rothblatt, Ph.D's compensation program. Senior Executive Promotions United Therapeutics announced the promotion of Roger Jeffs, Ph.D. to President and Co-Chief E...
Nov 13, 2014
SILVER SPRING, Md., Nov. 13, 2014 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) announced today the appointment of Professor Katherine J. Klein, Ph.D., of The Wharton School of the University of Pennsylvania to its Board of Directors as an independent director. The appointment is effective as of November 11, 2014. Professor ...
Oct 28, 2014
SILVER SPRING, Md., Oct. 28, 2014 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) today announced its financial results for the third quarter ended September 30, 2014. "We are pleased with our overall core operating results for the third quarter," said Martine Rothblatt, Ph.D., United Therapeutics' Chairman and Chief Executive...
Oct 21, 2014
SILVER SPRING, Md., Oct. 21, 2014 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) announced today that it will release its third quarter 2014 financial results before market open on Tuesday, October 28, 2014. United Therapeutics will host a half-hour teleconference on Tuesday, October 28, 2014, at 9:00 a.m. Eastern Time.  The ...
Aug 29, 2014
SILVER SPRING, Md., Aug. 29, 2014 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) announced today that the U.S. District Court for the District of New Jersey has ruled in its favor in the company's case against Sandoz, Inc. regarding United Therapeutics' Remodulin® product.  In his opinion, Judge Peter Sheridan ruled that U.S. P...
Jul 29, 2014
SILVER SPRING, Md., July 29, 2014 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) today announced its financial results for the second quarter ended June 30, 2014. "Our continued growth shows that our medicines are reaching increasing numbers of patients suffering from pulmonary arterial hypertension (PAH)," said Martine Rothb...
Jul 22, 2014
SILVER SPRING, Md., July 22, 2014 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) announced today that it will release its second quarter 2014 financial results before market open on Tuesday, July 29, 2014. United Therapeutics will host a half-hour teleconference on Tuesday, July 29, 2014, at 9:00 a.m. Eastern Time.  The telec...
1
... NextLast
= add release to Briefcase